Bcr/Abl P210-pLEF Citations (3)
Originally described in: Activity of the Bcr GTPase-activating domain is regulated through direct protein/protein interaction with the Rho guanine nucleotide dissociation inhibitor.Kweon SM, Cho YJ, Minoo P, Groffen J, Heisterkamp N J Biol Chem. 2008 Feb 8;283(6):3023-30. Epub 2007 Dec 10. PubMed Journal
Articles Citing Bcr/Abl P210-pLEF
| Articles |
|---|
| MAPK15 mediates BCR-ABL1-induced autophagy and regulates oncogene-dependent cell proliferation and tumor formation. Colecchia D, Rossi M, Sasdelli F, Sanzone S, Strambi A, Chiariello M. Autophagy. 2015 Oct 3;11(10):1790-802. doi: 10.1080/15548627.2015.1084454. PubMed |
One reporter for in-cell activity profiling of majority of protein kinase oncogenes.
Gudernova I, Foldynova-Trantirkova S, Ghannamova BE, Fafilek B, Varecha M, Balek L, Hruba E, Jonatova L, Jelinkova I, Kunova Bosakova M, Trantirek L, Mayer J, Krejci P.
Elife. 2017 Feb 15;6. pii: e21536. doi: 10.7554/eLife.21536.
PubMed
Associated Plasmids |
| TPEN/TPGS (T2) combo dramatically reduces Philadelphia chromosome-positive pro-lymphoblastic B leukemia in BALB/c mice. Mendivil-Perez M, Jimenez-Del-Rio M, Velez-Pardo C. Med Oncol. 2022 Nov 9;40(1):15. doi: 10.1007/s12032-022-01873-y. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.